These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3170513)

  • 21. Developmental expression of rat insulin-like growth factor binding protein-2 by astrocytic glial cells in culture.
    Olson JA; Shiverick KT; Ogilvie S; Buhi WC; Raizada MK
    Endocrinology; 1991 Aug; 129(2):1066-74. PubMed ID: 1713158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and properties of extracellular matrix-degrading metallo-proteinase overproduced by Rous sarcoma virus-transformed rat liver cell line, and its identification as transin.
    Umenishi F; Yasumitsu H; Ashida Y; Yamauti J; Umeda M; Miyazaki K
    J Biochem; 1990 Oct; 108(4):537-43. PubMed ID: 1963430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatomedin synthesis by a subclone of Buffalo rat liver cells: characterization and evidence for immediate secretion of de novo synthesized hormone.
    Mayer PW; Schalch DS
    Endocrinology; 1983 Aug; 113(2):588-95. PubMed ID: 6872942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine tumor cell growth-inhibiting activities from human malignant melanoma.
    Bogdahn U; Apfel R; Hahn M; Gerlach M; Behl C; Hoppe J; Martin R
    Cancer Res; 1989 Oct; 49(19):5358-63. PubMed ID: 2766302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity.
    Hsu YM; Wang JL
    J Cell Biol; 1986 Feb; 102(2):362-9. PubMed ID: 3944188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
    Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
    J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-domain peptide of rat proinsulin-like growth factor-II: validation of a radioimmunoassay and measurement in culture medium and rat serum.
    Hylka VW; Kent SB; Straus DS
    Endocrinology; 1987 May; 120(5):2050-8. PubMed ID: 3569124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation of Buffalo rat liver cells in serum-free medium does not depend upon multiplication-stimulating activity (MSA).
    Nissley SP; Short PA; Rechler MM; Podskalny JM; Coon HG
    Cell; 1977 Jun; 11(2):441-6. PubMed ID: 302146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.
    Böhmer FD; Lehmann W; Schmidt HE; Langen P; Grosse R
    Exp Cell Res; 1984 Feb; 150(2):466-76. PubMed ID: 6363109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on metalloproteinases and in vitro tumor invasion.
    Umenishi F; Umeda M; Miyazaki K
    J Biochem; 1991 Aug; 110(2):189-95. PubMed ID: 1662201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors.
    Theodoropoulos PA; Gravanis A; Saridakis I; Stournaras C
    Cell Biochem Funct; 1992 Dec; 10(4):281-8. PubMed ID: 1473269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for culturing chick melanocytes: the effect of BRL-3A cell conditioning and related additives.
    Giss B; Antoniou J; Smith G; Brumbaugh J
    In Vitro; 1982 Oct; 18(10):817-26. PubMed ID: 6757108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium.
    Coffer A; Fellows J; Young S; Pappin D; Rahman D
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):35-41. PubMed ID: 1831975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a growth inhibitory factor from hamster liver.
    Hashimoto C; Ayaki M; Inui Y
    Biochim Biophys Acta; 1994 Jan; 1220(2):107-17. PubMed ID: 8312355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: application of a monoclonal antibody.
    Tanaka H; Asami O; Hayano T; Sasaki I; Yoshitake Y; Nishikawa K
    Endocrinology; 1989 Feb; 124(2):870-7. PubMed ID: 2463906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis of the low molecular weight carrier protein for insulin-like growth factors in rat liver and fibroblasts.
    Romanus JA; Yang YW; Nissley SP; Rechler MM
    Endocrinology; 1987 Sep; 121(3):1041-50. PubMed ID: 2441976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of sarcoma growth inhibitor from avian sarcoma virus-transformed rat cells.
    Yamaoka K; Hirai R; Hiragun A
    Jpn J Cancer Res; 1986 Apr; 77(4):319-23. PubMed ID: 3009374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of medium conditioned with rat hepatoma BRL cells on '2-cell block' of random-bred mouse embryos cultured in vitro.
    Kobayashi M; Terawaki Y; Saito K; Kasuga K; Kojima I
    Zygote; 2009 May; 17(2):169-74. PubMed ID: 19187567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.